Several studies revealed that combinational therapy of both TGFβ and PD-L1 resulted in synergistic anti-tumor effect in both breast and colorectal cancers (Knudson et al., 2018; Tauriello et al., 2018). This evidence concerns the gene CD274 and neoplasm.